These constraints with the BTNX NTS are highly pertinent, as we found e.g. etodesnitazene to possess an analogous in vitro potency and efficacy as fentanyl [7, 13] and as it could perhaps give PWUD a false perception of security. Also, the detectability of nitazene analogues in drug samples may very well be impacted by solubility challenges, as hig